: Why India must urgently tackle the challenge of multidrug resistant pathogens #IndiaNEWS One evening in March 2019, one of us brought home their eight-and-a-half-month-old infant from an institution

@IndiaNEWS

Posted in: #IndiaNEWS

Why India must urgently tackle the challenge of multidrug resistant pathogens #IndiaNEWS
One evening in March 2019, one of us brought home their eight-and-a-half-month-old infant from an institution in southern India through adoption. The baby had a raging fever and both her ear drums were perforated, oozing pus and mucous. She had projectile diarrhoea and was severely malnourished and underweight. Over the course of the next three months, the parents ran from pillar to post across the country to find a cure for her recurrent ear infections. Bacterial cultures of the pus revealed that the baby had contracted a multidrug resistant Pseudomonas Aeruginosa infection while she was in the care of the institution. Multidrug resistance refers to the occurrence of pathogens against which multiple, otherwise effective, antimicrobial drugs are rendered ineffective. After five rounds of bacterial cultures, intravenous antibiotics, and multiple rounds of oral antibiotics, her parents discovered that she was unresponsive to first-line, second-line or third-generation antibiotics. When allopathy failed, they consulted alternative care practitioners. Nothing helped. Meanwhile, the baby gained weight with quality nutrition and care. The parents still do not know what finally helped but an old-school paediatrician told this harried pair that it was likely the baby’s own immune system that overcame the infection after six months of round-the-clock care. The ear...Read more

Intraday stocks under 50 NSE India Twitter of India

Vote Up Vote Down

Login to post a comment!